Pacific Biosciences of California (PACB) — Net Asset Quality Index
Pacific Biosciences of California (PACB) has a Net Asset Quality Index of -4.4% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $751.85 Million minus total liabilities of $785.06 Million yields net assets of $-33.21 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Pacific Biosciences of California (PACB) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Pacific Biosciences of California Net Asset Quality Index Over Time (2008–2025)
This chart shows how Pacific Biosciences of California's Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of June 2026, the index stands at -4.4%, representing net assets of $-33.21 Million against total assets of $751.85 Million USD. See shareholders equity of Pacific Biosciences of California for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Pacific Biosciences of California (2008–2025)
The table below presents the year-by-year Net Asset Quality Index for Pacific Biosciences of California from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see PACB company net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 0.7% | $5.35 Million | $784.08 Million | $778.73 Million | ▼ -39.5 pp |
| 2024 | 40.2% | $506.59 Million | $1.26 Billion | $753.85 Million | ▲ +0.0 pp |
| 2023 | 40.2% | $701.30 Million | $1.75 Billion | $1.04 Billion | ▲ +8.3 pp |
| 2022 | 31.9% | $562.90 Million | $1.77 Billion | $1.20 Billion | ▼ -7.6 pp |
| 2021 | 39.4% | $790.99 Million | $2.01 Billion | $1.22 Billion | ▼ -41.6 pp |
| 2020 | 81.0% | $335.49 Million | $413.98 Million | $78.49 Million | ▲ +43.9 pp |
| 2019 | 37.1% | $54.92 Million | $147.99 Million | $93.07 Million | ▼ -29.9 pp |
| 2018 | 67.0% | $114.06 Million | $170.28 Million | $56.21 Million | ▲ +7.2 pp |
| 2017 | 59.8% | $86.10 Million | $144.08 Million | $57.98 Million | ▼ -1.6 pp |
| 2016 | 61.4% | $84.67 Million | $137.88 Million | $53.22 Million | ▲ +5.3 pp |
| 2015 | 56.1% | $73.54 Million | $131.11 Million | $57.57 Million | ▲ +12.0 pp |
| 2014 | 44.1% | $54.95 Million | $124.52 Million | $69.57 Million | ▼ -6.7 pp |
| 2013 | 50.8% | $69.18 Million | $136.19 Million | $67.00 Million | ▼ -33.5 pp |
| 2012 | 84.3% | $109.38 Million | $129.68 Million | $20.30 Million | ▼ -3.4 pp |
| 2011 | 87.7% | $191.46 Million | $218.32 Million | $26.85 Million | ▼ -3.8 pp |
| 2010 | 91.5% | $279.87 Million | $305.75 Million | $25.88 Million | ▲ +266.7 pp |
| 2009 | -175.2% | $-177.12 Million | $101.10 Million | $278.22 Million | ▼ -92.6 pp |
| 2008 | -82.6% | $-93.39 Million | $113.11 Million | $206.50 Million | — |